InvestorsHub Logo
Followers 466
Posts 26950
Boards Moderated 2
Alias Born 09/11/2006

Re: surf1944 post# 2159

Tuesday, 05/01/2012 8:15:32 AM

Tuesday, May 01, 2012 8:15:32 AM

Post# of 2237
7:40AM POZEN reports EPS in-line, beats on revs; co is re-evaluating financial outlook for the year (POZN) 6.66 : Reports Q1 (Mar) loss of $0.28 per share, in-line with the Capital IQ Consensus Estimate consensus of ($0.28); revenues fell 71.1% year/year to $1.3 mln vs the $1.2 mln consensus. In light of the recent discussions with the FDA regarding the NDA for PA32540, they are re-evaluating their financial outlook for the year, which they will update when they complete their assessment.


surf's up......crikey